UB Paderborn / Katalog / Suche / in CDI

Should liver metastases of breast cancer be biopsied to improve treatment choice?

Annals of oncology, 2011-10, Vol.22 (10), p.2227-2233

2011

Volltextzugriff (PDF)

Sunitinib 2 weeks on, 1 off: strengths and weaknesses

Annals of oncology, 2015-07, Vol.26 (7), p.1511-1512

2015

Volltextzugriff (PDF)

2649 Prognostic role of PD-L1 expression in renal cell carcinoma (RCC): A systematic review and meta-analysis

European journal of cancer (1990), 2015-09, Vol.51, p.S530-S530

2015

Volltextzugriff (PDF)

2629 Incidence and prognostic role of cumulative toxicity by tyrosine kinase inhibitors (TKI) in metastatic renal cell carcinoma (mRCC)

European journal of cancer (1990), 2015-09, Vol.51, p.S522-S522

2015

Volltextzugriff (PDF)

2514 Incidence and relative-risk of cardiovascular toxicity in patients treated with new hormonal agents for metastatic castration-resistant prostate cancer (mCRPC)

European journal of cancer (1990), 2015-09, Vol.51, p.S479-S479

2015

Volltextzugriff (PDF)

Neo-adjuvant and adjuvant chemotherapy of gastric cancer

Annals of oncology, 2007-06, Vol.18 (suppl-6), p.vi120-vi123

2007

Volltextzugriff (PDF)

2830 A combined modality treatment with primary chemotherapy followed by Transoral Laser Microsurgery in intermediate stage laryngeal squamous cell carcinoma: A phase II study

European journal of cancer (1990), 2015-09, Vol.51, p.S568-S568

2015

Volltextzugriff (PDF)

Serum Vascular Endothelial Growth Factor (VEGF) Levels Correlate with Tumor VEGF and p53 Overexpression in Endocrine Positive Primary Breast Cancer

Cancer investigation, 2008-01, Vol.26 (3), p.250-255

2008

Volltextzugriff (PDF)

Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study

Annals of oncology, 2006-10, Vol.17 (10), p.1529-1532

2006

Volltextzugriff (PDF)

PO-1218: Oligo Metastatic renal cell carcinoma: SBRT, if, when and how?

Radiotherapy and oncology, 2020-11, Vol.152, p.S641-S642

2020

Volltextzugriff (PDF)

914PD - Prognostic factors in metastatic seminomatous germ cell tumours and elevated human chorionic gonadotrophin (HCG): A study of the G3

Annals of oncology, 2019-10, Vol.30, p.v363-v364

2019

Volltextzugriff (PDF)

Prognostic factors in metastatic seminomatous germ cell tumours and elevated human chorionic gonadotrophin (HCG): A study of the G3

Annals of oncology, 2019-10, Vol.30, p.v363-v364

2019

Volltextzugriff (PDF)

Carboplatin and etoposide chemotherapy in extrapulmonary poorly differentiated neuroendocrine carcinomas

Annals of oncology, 2015-10, Vol.26, p.vi138

2015

Volltextzugriff (PDF)

A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC)

Ecancermedicalscience, 2010-12, Vol.4, p.197

2010

Volltextzugriff (PDF)

Modified BEP chemotherapy in patients with testicular germ-cell tumors treated at a Comprehensive Cancer Center

Annals of oncology, 2016-09, Vol.27, p.iv29

2016

Volltextzugriff (PDF)

Incidence and relative-risk (RR) of cardiovascular toxicity in patients treated with new hormonal agents for metastatic castration-resistant prostate cancer (mCRPC)

Annals of oncology, 2015-10, Vol.26, p.vi58

2015

Volltextzugriff (PDF)

Incidence and prognostic role of cumulative toxicity by tyrosine kinase inhibitors (TKI) in metastatic renal cell carcinoma (mRCC)

Annals of oncology, 2015-10, Vol.26, p.vi55

2015

Volltextzugriff (PDF)

Bleomycin/cisplatin/etoposide Nausea, pulmonary toxicity and brain stroke: 3 case reports

Reactions weekly, 2020-08 (1819), p.69-69

Aurilio, G

2020

Volltextzugriff (PDF)

FDG PET scan (PET) positive residual lesions after chemotherapy (chemo) for metastatic seminoma: Results of an International Global Germ Cell Cancer Group (G3) registry

JOURNAL OF CLINICAL ONCOLOGY, 2017, Vol.35 (15_suppl), p.4521-4521

2017

Volltextzugriff (PDF)

246P Clinical utility of molecular tumor board in metastatic breast cancer

ESMO open, 2024-05, Vol.9, p.103267, Article 103267

2024

Volltextzugriff (PDF)

Prognostic role of PD-L1 expression in renal cell carcinoma. A systematic review and meta-analysis

Annals of oncology, 2015-10, Vol.26, p.vi57

2015

Volltextzugriff (PDF)

Clinical outcome of circulating tumor cells in metastatic castration-resistant prostate cancer patients treated with docetaxel: long-term prospective single-centre study

Annals of oncology, 2015-10, Vol.26, p.vi55

2015

Volltextzugriff (PDF)

A Meta-Analysis of Oestrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Discordance Between Primary Breast Cancer and Metastases

Annals of oncology, 2014-05, Vol.25, p.i8-i8

2014

Volltextzugriff (PDF)

41P Circulating Tumor Cells (CTCs) and Metronomic Oral Vinorelbine (OV) in Advanced Breast Cancer (ABC) Patients (PTS): Exploratory Prospective Analysis

Annals of oncology, 2012-05, Vol.23, p.ii26

2012

Volltextzugriff (PDF)

First-line therapy with metronomic capecitabine (mC) plus docetaxel (D) followed by mC as maintenance for patients with HER2-negative metastatic breast cancer (MBC): Preliminary analysis of a monocentric phase II trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11547-e11547

2011

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Should liver metastases of breast cancer be biopsied to improve treatment choice?

Sunitinib 2 weeks on, 1 off: strengths and weaknesses

2649 Prognostic role of PD-L1 expression in renal cell carcinoma (RCC): A systematic review and meta-analysis

2629 Incidence and prognostic role of cumulative toxicity by tyrosine kinase inhibitors (TKI) in metastatic renal cell carcinoma (mRCC)

2514 Incidence and relative-risk of cardiovascular toxicity in patients treated with new hormonal agents for metastatic castration-resistant prostate cancer (mCRPC)

Neo-adjuvant and adjuvant chemotherapy of gastric cancer

2830 A combined modality treatment with primary chemotherapy followed by Transoral Laser Microsurgery in intermediate stage laryngeal squamous cell carcinoma: A phase II study

Serum Vascular Endothelial Growth Factor (VEGF) Levels Correlate with Tumor VEGF and p53 Overexpression in Endocrine Positive Primary Breast Cancer

Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study

PO-1218: Oligo Metastatic renal cell carcinoma: SBRT, if, when and how?

914PD - Prognostic factors in metastatic seminomatous germ cell tumours and elevated human chorionic gonadotrophin (HCG): A study of the G3

Prognostic factors in metastatic seminomatous germ cell tumours and elevated human chorionic gonadotrophin (HCG): A study of the G3

Carboplatin and etoposide chemotherapy in extrapulmonary poorly differentiated neuroendocrine carcinomas

A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC)

Modified BEP chemotherapy in patients with testicular germ-cell tumors treated at a Comprehensive Cancer Center

Incidence and relative-risk (RR) of cardiovascular toxicity in patients treated with new hormonal agents for metastatic castration-resistant prostate cancer (mCRPC)

Incidence and prognostic role of cumulative toxicity by tyrosine kinase inhibitors (TKI) in metastatic renal cell carcinoma (mRCC)

Bleomycin/cisplatin/etoposide Nausea, pulmonary toxicity and brain stroke: 3 case reports

FDG PET scan (PET) positive residual lesions after chemotherapy (chemo) for metastatic seminoma: Results of an International Global Germ Cell Cancer Group (G3) registry

246P Clinical utility of molecular tumor board in metastatic breast cancer

Prognostic role of PD-L1 expression in renal cell carcinoma. A systematic review and meta-analysis

Clinical outcome of circulating tumor cells in metastatic castration-resistant prostate cancer patients treated with docetaxel: long-term prospective single-centre study

A Meta-Analysis of Oestrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Discordance Between Primary Breast Cancer and Metastases

41P Circulating Tumor Cells (CTCs) and Metronomic Oral Vinorelbine (OV) in Advanced Breast Cancer (ABC) Patients (PTS): Exploratory Prospective Analysis

First-line therapy with metronomic capecitabine (mC) plus docetaxel (D) followed by mC as maintenance for patients with HER2-negative metastatic breast cancer (MBC): Preliminary analysis of a monocentric phase II trial

Suchergebnisse filtern